Related references
Note: Only part of the references are listed.Genetic alterations associated with multiple primary malignancies
Jenny Nyqvist et al.
CANCER MEDICINE (2021)
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival
Megan M. Herr et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
Kazuna Tanba et al.
BLOOD CANCER JOURNAL (2018)
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival
Megan M. Herr et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors
Theresa H. M. Keegan et al.
JAMA ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era
Li Tao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008
Nicholas Donin et al.
CANCER (2016)
Current knowledge and future research directions in treatment-related second primary malignancies
Lindsay M. Morton et al.
EJC SUPPLEMENTS (2014)
Long-Term Complications of Lymphoma and Its Treatment
Andrea K. Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Apostolia-Maria Tsimberidou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study
Stefano Sacchi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients
Stefano Sacchi et al.
CANCER (2007)
Humoral immunity, inflammation and cancer
Ting-Ting Tan et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at the University of Texas M.D. Anderson Cancer Center
Q Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Second primary malignancies after treatment for malignant lymphoma
A Okines et al.
BRITISH JOURNAL OF CANCER (2005)
Improved survival of follicular lymphoma patients in the United States
WT Swenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte
P Feugier et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen:: a GELA cohort study on 2837 patients
M André et al.
BLOOD (2004)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
